Evidence map›Paper›PMID 35684161›Full record

ArticlePlants (Basel, Switzerland)2022

Isolation and Characterization of Werneria Chromene and Dihydroxyacidissimol from Burkillanthus malaccensis (Ridl.) Swingle

Masyitah Zulkipli, Nuzum Mahbub, Ayesha Fatima, Stefanie Lim Wan-Lin, Teng-Jin Khoo, Tooba Mahboob, Mogana Rajagopal, Chandramathi Samudi, Gheetanjali Kathirvalu, Nor Hayati Abdullah and 11 more

Open access · goldAbstract read
In one paragraph

Article in Plants (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 14 institutions in 7 countries.

Masyitah ZulkipliSchool of Pharmacy, University of Nottingham Malaysia Campus, Semenyih 43500, Malaysia.ORCID 0000-0002-4621-1511
Nuzum MahbubSchool of Pharmacy, University of Nottingham Malaysia Campus, Semenyih 43500, Malaysia.
Ayesha FatimaBeykoz Institute of Life Sciences and Biotechnology, Bezmialem Vakif University, Istanbul 34093, Turkey.ORCID 0000-0002-3181-2680
Stefanie Lim Wan-LinSchool of Pharmacy, University of Nottingham Malaysia Campus, Semenyih 43500, Malaysia.
Teng-Jin KhooSchool of Pharmacy, University of Nottingham Malaysia Campus, Semenyih 43500, Malaysia.
Tooba MahboobDepartment of Medical Microbiology, University of Malaya, Kuala Lumpur 50603, Malaysia.
Mogana RajagopalFaculty of Pharmaceutical Sciences, UCSI University, Kuala Lumpur 56000, Malaysia.ORCID 0000-0002-5664-9293
Chandramathi SamudiDepartment of Medical Microbiology, University of Malaya, Kuala Lumpur 50603, Malaysia.
Gheetanjali KathirvaluDepartment of Medical Microbiology, University of Malaya, Kuala Lumpur 50603, Malaysia.
Nor Hayati AbdullahNatural Product Division, Forest Research Institute Malaysia (FRIM), Kepong 52109, Malaysia.
Ana Rita PinhoDepartment of Medical Sciences, University of Aveiro, 3810-193 Aveiro, Portugal.ORCID 0000-0001-9815-7484
Sonia M R OliveiraCICECO-Aveiro Institute of Materials, University of Aveiro, 3810-193 Aveiro, Portugal.ORCID 0000-0002-0707-5203
Maria de Lourdes PereiraDepartment of Medical Sciences, University of Aveiro, 3810-193 Aveiro, Portugal.ORCID 0000-0001-6703-7869
Mohammed RahmatullahDepartment of Biotechnology & Genetic Engineering, University of Development Alternative, Lalmatia, Dhaka 1207, Bangladesh.ORCID 0000-0002-0216-7977
Anamul HasanDepartment of Biotechnology & Genetic Engineering, University of Development Alternative, Lalmatia, Dhaka 1207, Bangladesh.
Alok K PaulSchool of Pharmacy and Pharmacology, University of Tasmania, Hobart, TAS 7001, Australia.ORCID 0000-0002-6090-2407
Mark S ButlerInstitute for Molecular Bioscience, University of Queensland, Brisbane, QLD 4072, Australia.ORCID 0000-0001-6689-4236
Muhammad NawazDepartment of Nano-Medicine, Institute for Research and Medical Consultations (IRM), Imam Abdulrahman Bin Faisal University, Dammam 34212, Saudi Arabia.ORCID 0000-0001-9016-9229
Polrat WilairatanaDepartment of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand.ORCID 0000-0002-2730-7788
Veeranoot NissapatornSchool of Allied Health Sciences, World Union for Herbal Drug Discovery (WUHeDD), Research Excellence Center for Innovation and Health Products (RECIHP), Walailak University, Nakhon Si Thammarat 80160, Thailand.
Christophe WiartInstitute for Tropical Biology and Conservation, Universiti Malaysia Sabah, Jalan UMS, Kota Kinabalu 88400, Malaysia.
University of Nottingham Malaysia Campus · MYUniversity Malaya Medical Centre · MYUniversity of Aveiro · PTUniversity of Development Alternative · BDBezmiâlem Vakıf Üniversitesi · TRForest Research Institute Malaysia · MYHunter Medical Research Institute · AUImam Abdulrahman Bin Faisal University · SAMahidol University · THThe University of Queensland · AUUCSI University · MYUniversiti of Malaysia Sabah · MYUniversity of Tasmania · AUWalailak University · TH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The secondary metabolites of endemic plants from the Rutaceae family, such as Burkillanthusmalaccensis (Ridl.) Swingle from the rainforest of Malaysia, has not been studied. Burkillanthusmalaccensis (Ridl.) Swingle may produce antibacterial and antibiotic-potentiating secondary metabolites. Hexane, chloroform, and methanol extracts of leaves, bark, wood, pericarps, and endocarps were tested against bacteria by broth microdilution assay and their antibiotic-potentiating activities. Chromatographic separations of hexane extracts of seeds were conducted to investigate effective phytochemicals and their antibacterial activities. Molecular docking studies of werneria chromene and dihydroxyacidissiminol against SARS-CoV-2 virus infection were conducted using AutoDock Vina. The methanol extract of bark inhibited the growth of Staphylococcusaureus, Escherichiacoli, and Pseudomonasaeruginosa with the minimum inhibitory concentration of 250, 500, and 250 µg/mL, respectively. The chloroform extract of endocarps potentiated the activity of imipenem against imipenem-resistant Acinetobacterbaumannii. The hexane extract of seeds increased the sensitivity of P. aeruginosa against ciprofloxacin and levofloxacin. The hexane extract of seeds and chloroform extract of endocarps were chromatographed, yielding werneria chromene and dihydroxyacidissiminol. Werneria chromene was bacteriostatic for P.aeruginosa and P.putida, with MIC/MBC values of 1000 > 1000 µg/mL. Dihydroxyacidissiminol showed the predicted binding energies of −8.1, −7.6, −7.0, and −7.5 kcal/mol with cathepsin L, nsp13 helicase, SARS-CoV-2 main protease, and SARS-CoV-2 spike protein receptor-binding domain S-RBD. Burkillanthusmalaccensis (Ridl.) Swingle can be a potential source of natural products with antibiotic-potentiating activity and that are anti-SARS-CoV-2.

Indexed as

antibiotic potentiatorBurkillanthus malaccensiscathepsin Ldihydroxyacidissiminolnsp13 helicaseSARS-CoV-2spike proteinwerneria chromene

Identifiers

PMID35684161
PMCPMC9182682
OpenAlexW4282926678

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.